A pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours.

 
Web www.patentalert.com

> Type III secretion pathway in aeromonas salmonicida, and uses therefor

~ 00355